Tejava Ice Tea Recall Issued Due to Glass Fragment Contamination

A nationwide recall of Tejava Premium Iced Tea has been issued after it was discovered that some 12 oz bottles may be contaminated by glass fragments. 

The Tejava ice tea recall was announced by the FDA on December 9, after the company reported the problems.

Although there have been no reports of illness or injury resulting from the contaminated ice tea bottles, the manufacturer indicates that the glass fragments may be harmful if swallowed.

Do You Know About...

Childhood Diabetes Lawsuits Against Junk Food Industry

Lawyers are now pursing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods.

Learn More

The recall affects Tejava Premium Iced Tea in 12 oz. glass bottles with production lot code dates of 1BT220, 1BT221, 1BT222, 1BT223, 1BT252, 1BT253, 1BT254, 1BT255, 1BT277, 1BT278, 1BT279, 1BT280, and 1BT313. The production codes can be found on the back of the bottle label and on the long panel of the case tray. The cases the bottles were sold in have a UPC of 6-54871-24901-2, the four-packs have a UPC of 6-54871-04901-1, and the single bottles have a UPC of 6-54871-00901-5. The 1 liter bottles of Tejava Premium Iced Tea are not affected by the recall.

The company is asking consumers to return affected bottles of Tejava Premium Iced Tea to the store where it was purchased. The will receive coupons, product replacement or credit. Consumers with questions can call the Tejava Consumer Hotline at (888) 847-8742 or visit the company’s website at www.Tejava.com.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Class Action Lawsuit Seeks Medical Monitoring Due to Brain Tumor Risks
Depo-Provera Class Action Lawsuit Seeks Medical Monitoring Due to Brain Tumor Risks (Posted yesterday)

Pfizer and other manufacturers of the Depo-Provera birth control shot have been included in a class action lawsuit seeking medical monitoring for women who received the injections, due to the increased risk of brain tumors.

Another Influx of Suboxone Tooth Decay Lawsuits Expected in Coming Months
Another Influx of Suboxone Tooth Decay Lawsuits Expected in Coming Months (Posted 2 days ago)

The number of Suboxone lawsuits is expected to surge once again this summer, before a potential statute of limitations deadline in June 2025, for claims from states with a three-year statute of limitations.